Press Releases

Date	Title	Company
03-Sep-2021	Element strengthens North American Life Sciences business with acquisition of Impact Analytical	Element Materials Technology
03-Sep-2021	Moderna Announces Submission of Initial Data to U.S. FDA for Its COVID-19 Vaccine Booster	Moderna
03-Sep-2021	Sputnik V demonstrates 94.8% efficacy against COVID during the vaccination campaign in San Marino	Russian Direct Investment Fund
03-Sep-2021	Empagliflozin (Jardiance®) receives MHRA approval for the treatment of heart failure with reduced ejection fraction	Boehringer Ingelheim
03-Sep-2021	Novartis presents new findings at ERS reinforcing the efficacy of Enerzair® Breezhaler®, highlighting its digital companion, as well as showcasing commitment to low	Novartis
03-Sep-2021	Tiziana Life Sciences plc Posting of Scheme Document and Notice of Meetings	Tiziana Life Sciences
03-Sep-2021	Covid antibody levels are tumbling in the elderly, reveals new Government data. We must not let over-70s become booster jab guinea pigs, says expert	London Medical Laboratory
03-Sep-2021	NICE recommends Novartis Cosentyx® (secukinumab) for children and young people with moderate to severe psoriasis	Novartis
03-Sep-2021	Thermo Fisher Scientific Awarded $192.5 Million U.S. Government Contract to Expand Domestic Pipette Tip Manufacturing	Thermo Fisher Scientific
03-Sep-2021	Abbott Expands Peripheral Vascular Offerings With Acquisition of Walk Vascular, LLC	Abbott
03-Sep-2021	Half of all 16 and 17-year-olds receive life-saving COVID vaccine	NHS England
03-Sep-2021	Stephen Fry joins NHS campaign urging people to come forward for cancer checks	NHS England
03-Sep-2021	Evotec and Secarna Pharmaceuticals expand strategic partnership in the field of antisense drug discovery	Evotec and Secarna Pharmaceuticals
03-Sep-2021	Evotec announces Bristol Myers Squibb opt-in of EVT8683 as the first programme from iPSC-based neurodegeneration collaboration	Evotec
03-Sep-2021	Government subsidises medicine to combat high cholesterol in ‘high-risk’ Australians	Sanofi
03-Sep-2021	Novartis presents new findings at ERS reinforcing the efficacy of Enerzair® Breezhaler®, highlighting its digital companion, as well as showcasing commitment to low carbon footprint asthma solutions	Novartis
03-Sep-2021	Capital Markets Day BRAIN Biotech AG: Focus on BEC Technology and its Transformational Potential	BRAIN Biotech AG
03-Sep-2021	ADC Therapeutics Announces Medical Leadership Transition	Businesswire
03-Sep-2021	Global PCR For Respiratory Infection Diagnostic Market (2021 to 2028) - Use of PCR Testing for Various Respiratory Infection Diagnostics Presents Opportunities - ResearchAndMarkets.com	Businesswire
03-Sep-2021	Glaukos Announces Submission of Supplemental Pre-Market Approval Application for iStent infinite™	Businesswire